Crystallization and preliminary crystallographic studies of human TGF-beta type II receptor ligand-binding domain

Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1214-6. doi: 10.1107/s0907444902007357. Epub 2002 Jun 20.

Abstract

Three constructs (residues 15-136, 22-136 and 27-136) of the truncated extracellular domain of human transforming growth factor beta type II receptor (TBRII) were overexpressed in Escherichia coli. The constructs are referred to as TBRII(15-136), TBRII(22-136) and TBRII(27-136). The refolded receptors were purified using a combination of ion-exchange and size-exclusion chromatography. The purified receptors have an apparent molecular weight of 14 kDa as judged by size-exclusion chromatography. In the crystallization trials, TBRII(15-136) and TBRII(22-136) formed mostly crystal-like spheres but failed to produce data-quality crystals. TBRII(27-136) yielded large single crystals from hanging drops using the vapor-diffusion procedure with PEG 2000 or 4000 at pH 5.0. The crystals diffracted to 1.05 A [using the X9B beamline operated at lambda = 1.0092 A of the National Synchrotron Light Source (NSLS) at the Brookhaven National Laboratory] and belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 35.5, b = 40.7, c = 76.2 A. There was one molecule in the asymmetric unit, which corresponds to a solvent content of 42.1%.

MeSH terms

  • Chromatography
  • Chromatography, Ion Exchange
  • Cloning, Molecular
  • Crystallography, X-Ray / methods*
  • Escherichia coli / metabolism
  • Humans
  • Hydrogen-Ion Concentration
  • Ligands
  • Protein Serine-Threonine Kinases
  • Protein Structure, Tertiary
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / chemistry*
  • Synchrotrons
  • X-Ray Diffraction

Substances

  • Ligands
  • Receptors, Transforming Growth Factor beta
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II